Alzheimer's Disease Trial, Recruiting (NCT05597410)

Alzheimer's Disease Trial, Recruiting NCT05597410 Sponsor: Ruijin Hospital Condition: Alzheimer's Disease

Printed from Voxsanity (voxsanity.com.au) — NCT05597410 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Alzheimers Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have a close blood relative (parent, child, or full sibling) who has been diagnosed with Alzheimer's disease according to a recognised 2011 medical framework
People who have not been diagnosed with dementia
People aged 50 or older, of any gender
People who have lived in Shanghai for more than one year and have no plans to leave Shanghai within the next 5 years
People who are able to complete surveys, physical check-ups, brain imaging scans, and provide biological samples (such as blood)

Who may not be able to join:

People who have another condition known to affect memory or thinking, such as stroke-related brain disease, Creutzfeldt-Jakob disease, or Parkinson's disease
People who have a history of a psychological or psychiatric disorder, as defined by a standard medical diagnostic guide (DSM-5)
People who have vision or hearing difficulties that cannot be corrected and would prevent them from completing the required tests
Women who have not yet gone through menopause

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Gang Wang, MD, PhD, Ruijin Hospital

Phone: 086-021-64370045

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05597410

Sponsor: Ruijin Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Alzheimer's Disease

Trial contact: 086-021-64370045

More information: https://clinicaltrials.gov/study/NCT05597410

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have a close blood relative (parent, child, or full sibling) who has been diagnosed with Alzheimer's disease according to a recognised 2011 medical framework
People who have not been diagnosed with dementia
People aged 50 or older, of any gender
People who have lived in Shanghai for more than one year and have no plans to leave Shanghai within the next 5 years
People who are able to complete surveys, physical check-ups, brain imaging scans, and provide biological samples (such as blood)

Who may not be able to join:

People who have another condition known to affect memory or thinking, such as stroke-related brain disease, Creutzfeldt-Jakob disease, or Parkinson's disease
People who have a history of a psychological or psychiatric disorder, as defined by a standard medical diagnostic guide (DSM-5)
People who have vision or hearing difficulties that cannot be corrected and would prevent them from completing the required tests
Women who have not yet gone through menopause

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Ruijin Hospital

Registry

ClinicalTrials.gov

Start date

1 March 2022

Est. completion

1 March 2029

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Incidence of cognitive impairment at 5 years

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov